Karuna Therapeutics Inc

NASDAQ:KRTX   3:59:51 PM EDT
118.34
-0.96 (-0.80%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Karuna Therapeutics Inc Stock, NASDAQ:KRTX

99 High Street, 26th floor, Boston, Massachusetts 02110
Phone: +1.857.449.2244
Number of Employees: 63

Description

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA.